John Hayslip
Chief Tech/Sci/R&D Officer en VERASTEM, INC. .
Perfil
John Hayslip is currently the Chief Medical Officer at Verastem, Inc. He previously worked as the Director-Clinical Research & Data Management at The Markey Cancer Center Foundation and as the Vice President-Clinical Development at Nektar Therapeutics.
From 2022 to 2024, he served as the Chief Medical Officer at I-Mab.
Dr. Hayslip holds a graduate degree from the Medical University of South Carolina and a doctorate degree from Northeast Ohio Medical University.
Cargos activos de John Hayslip
| Empresas | Cargo | Inicio |
|---|---|---|
| VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 18/04/2024 |
Antiguos cargos conocidos de John Hayslip.
| Empresas | Cargo | Fin |
|---|---|---|
| I-MAB | Chief Tech/Sci/R&D Officer | 15/04/2024 |
| The Markey Cancer Center Foundation | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | - |
Formación de John Hayslip.
| Medical University of South Carolina | Graduate Degree |
| Northeast Ohio Medical University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| VERASTEM, INC. | Health Technology |
| I-MAB | Health Technology |
| Empresas privadas | 1 |
|---|---|
| The Markey Cancer Center Foundation |
- Bolsa de valores
- Insiders
- John Hayslip
